Overview

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and safety after treatment of Eutropin® inj. compared to Genotropin® in infants/toddlers with Prader-Willi syndrome
Phase:
Phase 3
Details
Lead Sponsor:
LG Life Sciences